← Open Payments lookup

KATHRYN LEE-YOUNG: Open Payments

NPI 1629495155 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,367 in 58 payments from 16 companies in 2025. Trend: 2023 $694 · 2024 $1,298 · 2025 $1,367

Food & beverage: $1,367
CompanyPaymentsAmount
Madrigal Pharmaceuticals12$264
Takeda Pharmaceuticals U.S.A., Inc.8$243
Ipsen Biopharmaceuticals, Inc8$202
ABBVIE INC.8$147
Gilead Sciences, Inc.4$103
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$75
ORPHALAN INC3$71
GENZYME CORPORATION2$56
Amgen Inc.2$38
Celltrion USA Inc.2$32

Products named: REZDIFFRA, ENTYVIO, IQIRVO, XIFAXAN, CREON, CUVRIOR, LINZESS, DUPIXENT.

Industry payments across MD — which companies pay providers there.